DCBSM, Duke Neurosurgery, Host Inaugural Brain & Spine Mets Colloqium (6.25 & 6.26)

Lung Brain mets PNAS article

DCBSM Inaugural colloqium ad

The Duke Center for Brain and Spine Metastasis at DCI (DCBSM) has established a Brain and Spine Metastasis Colloquium to bring together influential, multi-disciplinary leaders in the field.

The course directors are Cary Anders, MD; Peter Fecci, MD, PhD; Rory Goodwin, MD, PhD, and John Kirkparick, MD, PhD. 

Sponsored by Duke Neurosurgery, the inaugural colloquium — to be held virtually June 25-26, 2021 — will feature keynote talks and discussions with more than 50 internationally renowned leaders in the field of central nervous system metastasis. This multidisciplinary colloquium will cover medical oncology, radiation oncology,  palliative care, and neurosurgery, including case presentations and panel debates on emerging and pressing topics in the care of patients with brain and spine metastases.

The event, which is targeted at an academic audience, will be held via Zoom and is free-of-charge.

On the Agenda

Brain Metastasis

Ontogeny of Brain Metastases and Targeted Therapies
Medical Management of Breast Cancer and Lung Cancer CNS Metastasis
Medical Management of Melanoma and GU Cancer CNS Metastasis
Emerging Landscape of Melanoma Brain Metastasis Therapeutic Strategies
Optimal Care of Patients with Leptomeningeal Disease
Prognostic Factors in the Treatment of Brain Metastasis
Dose-Adapted Single-Isocenter Multi-target Stereotactic Radiosurgery (SIMT)
Current Approach to Brain Metastasis Patients: Radiotherapy and Supportive Care
Role of LITT in Progressive Brain Metastases
Multi-Sector Analysis of the Immuno-genomics of Brain Metastases
Approach to the Patient with Large, and/or Symptomatic Brain Metastasis: Pre-op Radiotherapy, Post-Op Radiotherapy or No-Op Radiotherapy
The Surgeon’s Approach to Radiographic Progression
Spine Metastasis

Radiotherapy Fractionation in Spine Stereotactic Body Radiotherapy (SBRT)
Minimally-invasive Surgical Treatment for Spine Metastases and Spine Tumors
Pain Management in Spine Metastasis Patients
Promising Advances in Metastatic Spine Disease
Blending Surgical and Scientific Advances:
To Screw or Not to Screw…RFA v Cryoablation vs. Interventional vs. RT Alone

Quality of Life and Supportive Care

Preservation of Neuro-Cognition and Quality of Life for Patients with Solid Tumor Brain Metastases
Communication with Serious Illness Patients and Families: Reducing Anxiety and Improving Goal-Concordant Care
Goal Concordant Care in Managing Spine Metastasis